Guggenheim Capital LLC Veracyte, Inc. Transaction History
Guggenheim Capital LLC
- $12 Billion
- Q4 2024
A detailed history of Guggenheim Capital LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 19,759 shares of VCYT stock, worth $812,292. This represents 0.01% of its overall portfolio holdings.
Number of Shares
19,759Holding current value
$812,292% of portfolio
0.01%Shares
8 transactions
Others Institutions Holding VCYT
# of Institutions
336Shares Held
81.1MCall Options Held
202KPut Options Held
18.6K-
Vanguard Group Inc Valley Forge, PA8.21MShares$338 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$320 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$271 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$173 Million1.46% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$168 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.94B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...